Cargando…
Rapid and exceptional response to Sonidegib in a patient with multiple locally advanced basal cell carcinomas
Locally advanced basal cell carcinoma (laBCC) represents a rare but possible occurrence in the vast scenario of dermatological diseases. It is well known that most BCC has a pathological activation of the hedgehog pathway, making them susceptible to targeted therapy with selective inhibitors. Sonide...
Autores principales: | Tarantino, Vanessa, Zavattaro, Elisa, Veronese, Federica, Gironi, Laura C., Savoia, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952046/ https://www.ncbi.nlm.nih.gov/pubmed/33534224 http://dx.doi.org/10.1097/CAD.0000000000001054 |
Ejemplares similares
-
Multiple Basal Cell Carcinomas in Immunocompetent Patients
por: Savoia, Paola, et al.
Publicado: (2022) -
Sonidegib treatment in patients with locally advanced basal cell carcinoma
por: Villani, Alessia, et al.
Publicado: (2022) -
Sonidegib for the Treatment of Advanced Basal Cell Carcinoma
por: Brancaccio, Gabriella, et al.
Publicado: (2020) -
Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas
por: Villani, Alessia, et al.
Publicado: (2022) -
Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
por: HERMS, Florian, et al.
Publicado: (2022)